Structural determinants within platelet glycoprotein Ibα involved in its binding to von willebrand factor

Platelets

Volumn 11, Issue 7, 2000, Pages 373-378

  Cauwenberghs, N ^a   Vanhoorelbeke, K ^a   Vauterin, S ^a   Deckmyn, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB; VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

THROMBUS;

EID: 0033635085     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100020019157     Document Type: Review

References (54)

1. Structure and function of von Willebrand factor
2. Generation and rescue of a murine model of platelet dysfunction: The Bernard-Soulier syndrome
3. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis
4. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates
5. Cellular transformation by coordinate action of three peptide growth factors from human platelets
6. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty
7. The platelet glycoprotein Ib-IX complex
8. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding
9. A new and reproducible vWF: RiCoF assay
10. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha- (1-289)
11. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood
12. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib
13. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca
14. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib
15. Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to- alanine scanning mutagenesis
16. Structure of the von Willebrand factor domain interacting with glycoprotein Ib
17. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets
18. Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin
19. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components
20. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor
21. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex
22. Requirement of leucine-rich repeats of glycoprotein (GP) Ibα for shear-dependent and static binding of von Willebrand factor to the platelet membrane GPIb-V-IX complex
23. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions
24. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
25. Von Willebrand factor binding to platelet GpIbeta initiates signals for platelet activation
26. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor
27. Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets
28. The platelet-collagen interaction
29. Characterization of murine anti-GPIb monoclonal antibodies that differentiate between shear-induced and risto/botrocetin-induced GPIb-vWF interaction
30. Characterisation and epitope-mapping of inhibitory anti-GPIb monoclonal antibodies
31. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling
32. Structure and function of the glycoprotein Ib-IX-V complex
33. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding
34. Localization of von Willebrand factor and thrombininteractive domains on human platelet glycoprotein Ib
35. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin
36. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding
37. A reduced and alkylated 52/48 kDa fragment beginning at amino residue 449 contains the domain interacting with platelet glycoprotein Ib
38. Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibα
39. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease
40. Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome
41. Naturally occurring mutations in glycoprotein Ibalpha that result in defective ligand binding and synthesis of a truncated protein
42. The role of the GPIbα leucine-rich repeats in binding of vWF to the GPIb-IX-V complex
43. Necessity of conserved asparagine residues in the leucine-rich repeats of platelet glycoprotein Ibα for the proper conformation and function of the ligand-binding region
44. Libraries of peptides and proteins displayed on filamentous phage
45. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor
46. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
47. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregation
48. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex
49. Platelet-type von Willebrand disease
50. Structural implications of the substitution of Val for Met at residue 239 in the α chain of human platelet glycoprotein Ib
51. Conformational energy analysis of the substitution of Val for Gly 233 in a functional region of platelet GPIbα in platelet-type von Willebrand disease
52. Mimotope/anti-mimotope probing of structural relationships in platelet glycoprotein Ib alpha
53. Platelet GPIb-V-IX complex
54. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field